Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AML.
- DOI
- 10.1016/j.leukres.2024.107497
- Published
- 2024 May
- Container
- Leukemia research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.leukres.2024.107497,
title = {Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AML.},
author = {Risueño A and See WL and Bluemmert I and de Botton S and DiNardo CD and Fathi AT and Schuh AC and Montesinos P and Vyas P and Prebet T and Gandhi A and Hasan M},
year = {2024},
journal = {Leukemia research},
doi = {10.1016/j.leukres.2024.107497},
url = {https://doi.org/10.1016/j.leukres.2024.107497}
}RIS
TY - JOUR TI - Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AML. AU - Risueño A AU - See WL AU - Bluemmert I AU - de Botton S AU - DiNardo CD AU - Fathi AT AU - Schuh AC AU - Montesinos P AU - Vyas P AU - Prebet T AU - Gandhi A AU - Hasan M PY - 2024 JO - Leukemia research DO - 10.1016/j.leukres.2024.107497 UR - https://doi.org/10.1016/j.leukres.2024.107497 ER -
APA
A, R., WL, S., I, B., S, D. B., CD, D., AT, F., AC, S., P, M., P, V., T, P., A, G., & M, H. (2024). Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AML.. Leukemia research. https://doi.org/10.1016/j.leukres.2024.107497
Source records
- pubmed · retrieved 2026-09-26T15:23:17.958Z